carbamazepine has been researched along with Diabetic Neuropathies in 46 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the long-term efficacy and safety of oxcarbazepine in symptoms of painful diabetic neuropathy." | 9.12 | Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy. ( Erdemoglu, AK; Varlibas, A, 2006) |
| "To assess the analgesic efficacy of carbamazepine in the treatment of chronic neuropathic pain and fibromyalgia, and to evaluate adverse events reported in the studies." | 8.90 | Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Kalso, EA; Moore, RA; Wiffen, PJ, 2014) |
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 8.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| " We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor." | 7.78 | Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012) |
| "OBJECTIVES - While carbamazepine (CBZ) decreases thyroid hormone concentrations it rarely causes hypothyroidism." | 7.74 | Carbamazepine and risk of hypothyroidism: a prospective study. ( Horacek, J; Simko, J, 2007) |
| "Neuropathic pain is the most severe and resistant type of pain which has impact on quality of life and behaviour; it most commonly occurs at night causing disturbed sleep." | 6.84 | Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy. ( Jawed, I; Kamil, A; Khan, MI; Mahmood, I; Mahmood, R; Sayeed, BZ; Sayeed, FZ; Tariq, T, 2017) |
| " For treating trigeminal neuralgia, carbamazepine had a combined number needed to treat of 2." | 6.17 | Anticonvulsant drugs for management of pain: a systematic review. ( Carroll, D; Jadad, AR; McQuay, H; Moore, A; Wiffen, P, 1995) |
| "To investigate the long-term efficacy and safety of oxcarbazepine in symptoms of painful diabetic neuropathy." | 5.12 | Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy. ( Erdemoglu, AK; Varlibas, A, 2006) |
| "This review found little evidence to support the effectiveness of oxcarbazepine in painful diabetic neuropathy, neuropathic pain from radiculopathy and a mixture of neuropathies." | 4.95 | Oxcarbazepine for neuropathic pain. ( Chen, N; He, L; Wu, F; Yang, M; Zhou, M; Zhu, C, 2017) |
| "To assess the analgesic efficacy of carbamazepine in the treatment of chronic neuropathic pain and fibromyalgia, and to evaluate adverse events reported in the studies." | 4.90 | Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. ( Derry, S; Kalso, EA; Moore, RA; Wiffen, PJ, 2014) |
| " Three of them investigated oxcarbazepine in people with painful diabetic neuropathy (634 participants) and one was a trial of oxcarbazepine for neuropathic pain due to radiculopathy (145 participants)." | 4.89 | Oxcarbazepine for neuropathic pain. ( Chen, N; He, L; Wu, F; Yang, M; Zhou, M; Zhu, C, 2013) |
| " Increasing evidence suggests that oxcarbazepine can provide significant analgesia in several neuropathic pain conditions, including trigeminal neuralgia and PDN, and is also may be effective in treating neuropathic pain refractory to other AEDs, such as carbamazepine and gabapentin." | 4.82 | Rationale and evidence for the use of oxcarbazepine in neuropathic pain. ( Carrazana, E; Mikoshiba, I, 2003) |
| "Tricyclic antidepressants and carbamazepine have become the mainstay in the treatment of neuropathic pain." | 4.80 | Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. ( Jensen, TS; Sindrup, SH, 1999) |
| " We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor." | 3.78 | Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor. ( Dardis, C; Ly, V; Omoregie, E, 2012) |
| "OBJECTIVES - While carbamazepine (CBZ) decreases thyroid hormone concentrations it rarely causes hypothyroidism." | 3.74 | Carbamazepine and risk of hypothyroidism: a prospective study. ( Horacek, J; Simko, J, 2007) |
| "Neuropathic pain is the most severe and resistant type of pain which has impact on quality of life and behaviour; it most commonly occurs at night causing disturbed sleep." | 2.84 | Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy. ( Jawed, I; Kamil, A; Khan, MI; Mahmood, I; Mahmood, R; Sayeed, BZ; Sayeed, FZ; Tariq, T, 2017) |
| "Oxcarbazepine was initiated at 300 mg/day and titrated over 4 weeks to tolerability or a maximum dose of 900 mg b." | 2.73 | Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. ( Alarcón, F; Beydoun, S; Mangat, S; Wan, Y, 2007) |
| "Oxcarbazepine was initiated at a dose of 300 mg/day and titrated to a maximum dose of 1800 mg/day." | 2.71 | Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. ( Beydoun, S; Dogra, S; Hopwood, M; Mazzola, J; Wan, Y, 2005) |
| "Chronic pain is now viewed as a biopsychosocial phenomenon, in which biological, psychological, and social factors are at work." | 2.44 | Practical management strategies for the chronic pain patient. ( Forde, G; Stanos, S, 2007) |
| "Neuropathic pain is a frequent condition that can result from a variety of underlying conditions and is frequently chronic and difficult to treat." | 2.44 | Oxcarbazepine in neuropathic pain. ( Beydoun, A; Nasreddine, W, 2007) |
| "Treatment with carbamazepine (CBZ) is known to affect apolipoprotein B-containing lipoprotein concentrations in serum." | 1.32 | Lipoprotein(a) concentration increases during treatment with carbamazepine. ( Berthold, HK; Brämswig, S; Luers, C; Sudhop, T; von Bergmann, K, 2003) |
| "Erythromelalgia is a syndrome characterized by erythema, burning pain and increased skin temperature of the affected extremities." | 1.27 | Erythromelalgia associated with acute diabetic neuropathy: an unusual condition. ( Bosch, X; Esmatjes, E; Goday, A; Gomis, R; Nubiola, A; Vendrell, J; Vilardell, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (19.57) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 18 (39.13) | 29.6817 |
| 2010's | 12 (26.09) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sherbeeny, NA | 1 |
| Ibrahiem, AT | 1 |
| Ali, HS | 1 |
| Farag, NE | 1 |
| Toraih, EA | 1 |
| Zaitone, SA | 1 |
| Sindrup, SH | 2 |
| Holbech, J | 1 |
| Demant, D | 1 |
| Finnerup, NB | 1 |
| Bach, FW | 1 |
| Jensen, TS | 2 |
| Mahmood, R | 1 |
| Jawed, I | 1 |
| Khan, MI | 1 |
| Mahmood, I | 1 |
| Tariq, T | 1 |
| Kamil, A | 1 |
| Sayeed, FZ | 1 |
| Sayeed, BZ | 1 |
| Zhou, M | 2 |
| Chen, N | 2 |
| He, L | 2 |
| Yang, M | 2 |
| Zhu, C | 2 |
| Wu, F | 2 |
| Han, C | 1 |
| Themistocleous, AC | 1 |
| Estacion, M | 1 |
| Dib-Hajj, FB | 1 |
| Blesneac, I | 1 |
| Macala, L | 1 |
| Fratter, C | 1 |
| Bennett, DL | 1 |
| Waxman, SG | 1 |
| Dib-Hajj, SD | 1 |
| Bektas, N | 1 |
| Arslan, R | 1 |
| Ozturk, Y | 1 |
| Wiffen, PJ | 1 |
| Derry, S | 1 |
| Moore, RA | 1 |
| Kalso, EA | 1 |
| Razazian, N | 1 |
| Baziyar, M | 1 |
| Moradian, N | 1 |
| Afshari, D | 1 |
| Bostani, A | 1 |
| Mahmoodi, M | 1 |
| Forde, G | 1 |
| Stanos, S | 1 |
| Eyigor, C | 1 |
| Uyar, M | 1 |
| Pirildar, S | 1 |
| Coker, M | 1 |
| Kaliyadan, F | 1 |
| Ray, S | 1 |
| Mathew, MK | 1 |
| Pai, S | 1 |
| Sasikala, L | 1 |
| Pai, R | 1 |
| Varsavsky, M | 1 |
| Quesada Charneco, M | 1 |
| Rozas Moreno, P | 1 |
| Brick, N | 1 |
| Gordeev, SA | 1 |
| Turbina, LG | 1 |
| Zus'man, AA | 1 |
| Posokhov, SI | 1 |
| Dardis, C | 1 |
| Omoregie, E | 1 |
| Ly, V | 1 |
| Suzuki, K | 1 |
| Kimura, M | 1 |
| Brämswig, S | 1 |
| Sudhop, T | 1 |
| Luers, C | 1 |
| von Bergmann, K | 1 |
| Berthold, HK | 1 |
| Carrazana, E | 1 |
| Mikoshiba, I | 1 |
| Dogra, S | 1 |
| Beydoun, S | 2 |
| Mazzola, J | 2 |
| Hopwood, M | 3 |
| Wan, Y | 4 |
| Beydoun, A | 2 |
| Shaibani, A | 1 |
| Buescher, JJ | 1 |
| Erdemoglu, AK | 1 |
| Varlibas, A | 1 |
| Grosskopf, J | 1 |
| Medvedeva, LA | 1 |
| Gnezdilov, AV | 1 |
| Zagorul'ko, OI | 1 |
| Syrovegin, AV | 1 |
| Samoĭlova, NV | 1 |
| Slashchuk, IuI | 1 |
| Alarcón, F | 1 |
| Mangat, S | 1 |
| Wernicke, JF | 1 |
| Wang, F | 1 |
| Pritchett, YL | 1 |
| Smith, TR | 1 |
| Raskin, J | 1 |
| D'Souza, DN | 1 |
| Iyengar, S | 1 |
| Chappell, AS | 1 |
| Simko, J | 1 |
| Horacek, J | 1 |
| Nasreddine, W | 1 |
| Clements, RS | 1 |
| McQuay, H | 1 |
| Carroll, D | 1 |
| Jadad, AR | 1 |
| Wiffen, P | 1 |
| Moore, A | 1 |
| Strian, F | 1 |
| Haslbeck, M | 1 |
| Standl, E | 1 |
| Steiner, I | 1 |
| Birmanns, B | 1 |
| Gómez-Pérez, FJ | 1 |
| Choza, R | 1 |
| Ríos, JM | 1 |
| Reza, A | 1 |
| Huerta, E | 1 |
| Aguilar, CA | 1 |
| Rull, JA | 2 |
| Azulay, JP | 1 |
| Pouget, J | 1 |
| Yamada, N | 1 |
| Kaneko, K | 1 |
| Saito, Y | 1 |
| Tatsuno, I | 1 |
| Lovrien, F | 1 |
| Shipp, JC | 1 |
| Chakrabarti, AK | 1 |
| Samantaray, SK | 1 |
| Badran, AM | 1 |
| Aly, MA | 1 |
| Sous, ES | 1 |
| Ziegler, D | 1 |
| Gries, FA | 1 |
| Schapira, D | 1 |
| Barron, SA | 1 |
| Nahir, M | 1 |
| Scharf, Y | 1 |
| Vendrell, J | 1 |
| Nubiola, A | 1 |
| Goday, A | 1 |
| Bosch, X | 1 |
| Esmatjes, E | 1 |
| Gomis, R | 1 |
| Vilardell, E | 1 |
| Wilton, TD | 1 |
| Fernández Alvarez, O | 1 |
| Quibrera, R | 1 |
| González-Millán, H | 1 |
| Lozano Castañeda, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Electroacupuncture Therapy for Change of Pain in Classical Trigeminal Neuralgia[NCT03580317] | 120 participants (Actual) | Interventional | 2018-07-12 | Completed | |||
| Efficacy of Pregabalin and Duloxetine in Patients With Painful Diabetic Peripheral Neuropathy (PDPN): the Effect of Pain on Cognitive Function, Sleep and Quality of Life (BLOSSOM)[NCT04246619] | Phase 4 | 254 participants (Actual) | Interventional | 2019-11-12 | Terminated (stopped due to The statistical analysis will still provide relevant results with the same statistical power as initially planned.COVID-19 pandemic prolonged the recruiting period and consequently affected the costs of the clinical trial.) | ||
| Erenumab as a Therapeutic Approach for the Management of Trigeminal Neuropathic Pain (TNP)[NCT05142228] | Phase 2 | 5 participants (Actual) | Interventional | 2022-04-01 | Terminated (stopped due to Low enrollment rate) | ||
| Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury[NCT00167856] | 16 participants (Actual) | Interventional | 2005-06-30 | Completed | |||
| Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)[NCT01623271] | 5 participants (Actual) | Interventional | 2013-05-31 | Terminated (stopped due to Due to limited population of research participants.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Subjects rated their pain using the VAS at visit 3, which was the last day of their maintenance phase. After this visit, subjects begin to taper the gralise. The VAS is subject reported on a scale of 0-10 with 0 being no pain and 10 being the worst pain they can imagine. Results reported are an average of the 3 subjects who completed visit 3. (NCT01623271)
Timeframe: At visit 3
| Intervention | units on the VAS (Mean) |
|---|---|
| CRPS I Pain Subjects | 3.67 |
11 reviews available for carbamazepine and Diabetic Neuropathies
| Article | Year |
|---|---|
Oxcarbazepine for neuropathic pain.
Topics: Analgesics, Non-Narcotic; Carbamazepine; Diabetic Neuropathies; Humans; Neuralgia; Numbers Needed To | 2017 |
Oxcarbazepine for neuropathic pain.
Topics: Analgesics, Non-Narcotic; Carbamazepine; Diabetic Neuropathies; Humans; Neuralgia; Oxcarbazepine; Ra | 2013 |
Carbamazepine for chronic neuropathic pain and fibromyalgia in adults.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Chronic Pain; Diabetic Neuropathies; Fibromyalgia; H | 2014 |
Practical management strategies for the chronic pain patient.
Topics: Administration, Cutaneous; Amines; Analgesics; Antidepressive Agents, Tricyclic; Carbamazepine; Chro | 2007 |
Carbamazepine for acute and chronic pain in adults.
Topics: Acute Disease; Analgesics, Non-Narcotic; Carbamazepine; Chronic Disease; Diabetic Neuropathies; Huma | 2011 |
[Sensory disorder and clinical care in painful diabetic neuropathy].
Topics: Antidepressive Agents; Capsaicin; Carbamazepine; Chronic Disease; Clonidine; Diabetic Neuropathies; | 2002 |
Rationale and evidence for the use of oxcarbazepine in neuropathic pain.
Topics: Anticonvulsants; Carbamazepine; Central Nervous System Diseases; Clinical Trials as Topic; Diabetic | 2003 |
Oxcarbazepine in neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Humans; Ne | 2007 |
Anticonvulsant drugs for management of pain: a systematic review.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diabetic Neuropathies; Humans; Pain; Phenytoin; Treatmen | 1995 |
[Treatment of painful diabetic neuropathies].
Topics: Analgesics; Analgesics, Opioid; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Combined | 1994 |
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Diabetic Neuropathies; Humans; | 1999 |
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Diabetic Neuropathies; Humans; | 1999 |
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Diabetic Neuropathies; Humans; | 1999 |
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.
Topics: Analgesics; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Diabetic Neuropathies; Humans; | 1999 |
14 trials available for carbamazepine and Diabetic Neuropathies
| Article | Year |
|---|---|
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Carbamazepine; Diabetic Neuropathies; Female; H | 2017 |
Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy.
Topics: Analgesics, Non-Narcotic; Carbamazepine; Diabetic Neuropathies; Female; Humans; Male; Medical Record | 2017 |
Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.
Topics: Adult; Affect; Aged; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Cyclohexanols; Diabetic Ne | 2014 |
Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Analgesics; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Dose-Res | 2005 |
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.
Topics: Adult; Aged; Analgesics; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Dizziness; Dose-Resp | 2006 |
Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Hu | 2006 |
A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Double-Blind | 2006 |
[Neurometabolic therapy of diabetic neuropathy].
Topics: Adjuvants, Immunologic; Analgesics, Non-Narcotic; Antioxidants; Blood Glucose; Carbamazepine; Diabet | 2006 |
Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Double-Blind Method; Drug Admini | 2007 |
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Topics: Acetaminophen; Amitriptyline; Analgesics; Carbamazepine; Diabetes Complications; Diabetic Neuropathi | 2007 |
Anticonvulsant drugs for management of pain: a systematic review.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diabetic Neuropathies; Humans; Pain; Phenytoin; Treatmen | 1995 |
Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.
Topics: Adult; Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Carbamazepine; Cross-Over Studies | 1996 |
Tegretol in the treatment of diabetic neuropathy.
Topics: Adult; Aged; Attitude of Health Personnel; Attitude to Health; Carbamazepine; Clinical Trials as Top | 1974 |
Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.
Topics: Adult; Aged; Carbamazepine; Clinical Trials as Topic; Diabetic Neuropathies; Dibenzazepines; Female; | 1969 |
22 other studies available for carbamazepine and Diabetic Neuropathies
| Article | Year |
|---|---|
Carbamazepine conquers spinal GAP43 deficiency and sciatic Nav1.5 upregulation in diabetic mice: novel mechanisms in alleviating allodynia and hyperalgesia.
Topics: Alloxan; Animals; Carbamazepine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Mod | 2020 |
The Novel Activity of Carbamazepine as an Activation Modulator Extends from Na
Topics: Aged; Animals; Carbamazepine; Diabetic Neuropathies; Female; Ganglia, Spinal; Humans; Male; Membrane | 2018 |
Zonisamide: Antihyperalgesic efficacy, the role of serotonergic receptors on efficacy in a rat model for painful diabetic neuropathy.
Topics: Animals; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Disease Models, Animal; Dose-Respons | 2014 |
Combination therapy in treatment of peripheral diabetic neuropathy with severe pain in an adolescent patient.
Topics: Administration, Cutaneous; Adolescent; Amines; Analgesics; Carbamazepine; Cyclohexanecarboxylic Acid | 2009 |
A rapidly progressing, fatal case of primary systemic anaplastic large cell lymphoma presenting as erythroderma--association with carbamazepine.
Topics: Aged; Carbamazepine; Dermatitis, Exfoliative; Diabetic Neuropathies; Disease Progression; Fatal Outc | 2008 |
[Urea as therapeutic option for the treatment of the syndrome of inappropriate antidiuretic hormone secretion].
Topics: Amitriptyline; Carbamazepine; Comorbidity; Demeclocycline; Diabetic Neuropathies; Diuretics; Furosem | 2011 |
[The state of nociceptive and antinociceptive brain systems in patients with the pain form of diabetic polyneuropathy].
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Brain; Carbamazepine; Cyclohexanols; Diabetic N | 2011 |
Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.
Topics: Aged, 80 and over; Analgesics; Antihypertensive Agents; Atrial Fibrillation; Bronchodilator Agents; | 2012 |
Lipoprotein(a) concentration increases during treatment with carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabe | 2003 |
Carbamazepine for acute and chronic pain.
Topics: Acute Disease; Analgesics, Non-Narcotic; Carbamazepine; Chronic Disease; Diabetic Neuropathies; Huma | 2006 |
Carbamazepine and risk of hypothyroidism: a prospective study.
Topics: Adult; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Down-Regulation; Epilepsy; Humans; Hyp | 2007 |
What's new for neuropathic syndromes.
Topics: Carbamazepine; Cholinesterase Inhibitors; Diabetic Neuropathies; Female; Humans; Male; Parasympathom | 1980 |
Carbamazepine-induced urinary retention in long-standing diabetes mellitus.
Topics: Aged; Aged, 80 and over; Carbamazepine; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Ur | 1993 |
[Diabetic neuropathies].
Topics: Acetates; Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Controlled Clinic | 2001 |
Anticonvulsant hypersensitivity syndrome with marked eosinophilia in treatment of diabetic neuropathy.
Topics: Adult; Anticonvulsants; Carbamazepine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Hypers | 2002 |
Diabetic neuropathy: clinical manifestations, diagnosis, and management.
Topics: Animals; Carbamazepine; Diabetic Neuropathies; Humans; Male; Middle Aged; Procaine; Rats | 1976 |
Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy.
Topics: Adult; Aged; Carbamazepine; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neural Conduct | 1976 |
A clinical trial of carbamazepine in the symptomatic treatment of diabetic peripheral neuropathy.
Topics: Adult; Aged; Carbamazepine; Diabetic Neuropathies; Female; Humans; Male; Middle Aged | 1975 |
[Treatment of pain in diabetic polyneuropathy].
Topics: Analgesics; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Carbamaze | 1991 |
Reflex sympathetic dystrophy syndrome coincident with acute diabetic neuropathy.
Topics: Bone Diseases, Metabolic; Carbamazepine; Diabetic Neuropathies; Female; Humans; Middle Aged; Reflex | 1988 |
Erythromelalgia associated with acute diabetic neuropathy: an unusual condition.
Topics: Acute Disease; Adult; Carbamazepine; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Erythromelalg | 1988 |
[Tegretol in diabetic neuropathies].
Topics: Adult; Aged; Carbamazepine; Diabetic Neuropathies; Drug Evaluation; Female; Humans; Male; Middle Age | 1974 |